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During a screening program for bioactive natural products, a potential Streptomyces sp was isolated from soil. On
the basis of biochemical, cultural, physiological and 16S rRNA gene analysis, it was identified as Streptomyces
purpurascens. The isolate was grown in liquid medium and the crude antibiotic complex was obtained by ethyl
acetate extraction. Seven purified fractions were obtained by preparative Thin Layer Chromatography (TLC). Acid
hydrolysis of each fraction and subsequent TLC led to the identification of aglycones and sugars indicating these
compounds to be Rhodomycin and its analogues. The identity of these compounds was established on the basis
of UV-visible and FT-IR spectra and comparison with published data. The compounds were active against Gram-
positive bacteria. Compound E, identified as Rhodomycin B, was found to be the most potent compound with an
MIC of 2 μg/ml against Bacillus subtilis. Compounds A and F identified as α2-Rhodomycin II and Obelmycin
respectively, and Compound E exhibited an IC50 of 8.8 μg/ml against HeLa cell line but no cytotoxicity was found
against L929.
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Anthracyclines, which include rhodomycins, are among
the most widely studied natural products of Streptomyces
sp. over the past quarter century (Vaněk et al. 1977). They
attract attention because of their intense color that ranges
from yellow and red to purple and blue. They belong to
the group of aromatic polyketides where the basic struc-
ture is a cyclic polyketide backbone that shares the 7, 8, 9,
10-tetrahydrotetracene-5, 12-quinone structure. The di-
versity of these secondary metabolites is based on the
structural differences in the aglycone and the different
sugar residues attached (Additional file 1).
The anthracycline antibiotics have gathered atten-
tion of the chemists due to their outstanding antibac-
terial and antitumor activities (Hortobagyi 1997).
Rhodomycin was the first anthracycline compound
identified by H. Brockmann in 1963(Brockmann &
Bauer 1950). Since then many members of the* Correspondence: sbundale@gmail.com
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in any medium, provided the original work is panthracycline family have been discovered with a
broad spectrum of activity. These include daunorubi-
cin, doxorubicin, idarubicin, epirubicin, zorubicin and
aclacinomycin A, all of which are obtained from
Streptomyces sp. The clinical use of these drugs, how-
ever has been hampered by a number of undesirable
side effects, the most serious being the dose related
cardiotoxicity (Jones 1993; Rahman et al. 2007). There
is therefore, a great interest in related natural or syn-
thetic compounds having improved therapeutic indi-
ces. Many efforts have been made to modify the
anthracycline molecule with the objective of develop-
ing analogues with a wider spectrum of activity and
reduced toxicity (Taatjes et al. 1996;Gianni et al.
2008). Also efforts have been directed towards
obtaining hybrid anthracyclines with less toxicity.
However, the complexity of the structure and biosyn-
thetic pathway of anthracyclines have posed difficul-
ties in these efforts (Jansson et al. 2003).
Soil is a natural reservoir for microorganisms, particu-
larly the spore forming Streptomyces and their antimicro-
bial products. It is a known fact that Streptomyces are ann Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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have been extensively screened by the pharmaceutical in-
dustry for about 50 years, only a small fraction of the sur-
face of the globe has been sampled, and only a small
fraction of Streptomyces taxa has been discovered. There
is a strong circumstantial evidence that the discovery of
previously unknown natural products occurs when novel
organisms are examined in either established or new
pharmacological screening programs (Takahashi & Omura
2003). There are probably many unexplored anthracycline
producing Streptomyces in soil which are yet to be discov-
ered and may have an answer to this glaring problem.
With this intention, a Streptomyces sp. was isolated
from soil and investigated for several bioactivities. It has
been identified as Streptomyces purpurascens and depos-
ited in the Microbial Type Culture Collection (MTCC),
Chandigarh, India (http://mtcc.imtech.res.in/) with the
accession number MTCC 8547. The red colored ethyl
acetate cell extract of the isolate showed a high anti-
microbial activity and the TLC delivered several red and
orange zones. In the present study we report isolation,
taxonomy of the isolate, its antimicrobial and anticancer
activities, partial purification and characterization of the
anthracyclines produced.Material and methods
Isolation of the microorganism
In a systematic screening program for isolation of bio-
active Streptomyces, soil samples from different locations
in and around Nagpur, Maharashtra, India, were collected
and stored at -20°C. The soil samples were pretreated by
heating at 60°C for 10 minutes. 1 g each of the treated soil
sample was serially diluted at 1:10 and 1:100 in sterile dis-
tilled water and plated on Starch-casein (SC) agar plates
(Thakur et al. 2007). The SC agar plates were incubated
for 14 days at 30°C and the resulting colonies were
subcultured and maintained on Yeast extract-malt extract
(YEME) agar (Ouhdouch et al. 2001;Smaoui et al. 2012).
Unless otherwise mentioned, all the chemicals and sol-
vents were purchased from Merck and culture media
from Hi-media laboratories, Mumbai.Identification of the isolate
The morphological and cultural characteristics of the
isolate were assessed in accordance with the method de-
scribed by Shirling and Gottlieb (1966); Thakur et al.
(2007),. Cultural characteristics were observed on YEME
agar (ISP2), Oatmeal agar (ISP3), Inorganic salt Starch
agar (ISP4), and Glycerol Asparagine agar (ISP5) after
14 days of culturing at 28°C. The morphological charac-
teristics were assessed via light microscopy of 7-day old
cultures grown on ISP4. Color of aerial mycelium was
determined from mature, sporulating aerial mycelia ofthe Streptomyces colonies on SC agar media (Pridham
et al. 1958).
The presence of soluble pigments and the melanoid
pigment was investigated on (ISP 2) and peptone yeast
extract iron agar (ISP 6).
The diagnostic isomers of diaminopimelic acid (DAP)
and whole-organism sugars of the isolate were analyzed by
the procedure developed by Becker et al.(1965) Utilization
of various carbon and nitrogen sources was examined.
Each source was added at a final concentration of 1% (w/
v) and 0.1% (w/v) respectively. Degradation of starch was
determined according to Gordon et al. (1974). Growth
in the presence of sodium chloride was determined ac-
cording to Tresner et al. (1971) and temperature and pH
requirements were assessed on ISP 2 medium.
Molecular characterization of the isolate
A confirmatory taxonomic identification was done by the
nucleotide sequencing of the 16S rRNA gene. Genomic
DNA extraction, amplification and sequencing of the 16S
rRNA gene were performed as described earlier (Mayilraj
et al. 2006). The 16S rRNA gene was amplified with
primers 8-27f (5′-AGAGTTTGATCCTGGCTCAG-3')
and 1500r (5′AGAAAGGAGGTGATCCAGCCA-3′). The
amplified DNA fragment was separated on 1% agarose gel,
eluted from the gel and purified using QIAquick gel extrac-
tion kit (Qiagen). The purified PCR product was sequenced
with 27f, 519r (5-GWATTACCGCGGCKGCTG-3), 1087r
(5-CTCGTTGCGGGACTTAACCC-3), 530f (5-TTCGTG
CCAGCAGCCGCGG-3), 945f (5-GGGCCCGCACAAGC
GGTGG-3) and 1492r respectively (Escherichia coli num-
bering system). The rDNA sequence was determined by
the dideoxy chain-termination method using the Big-Dye
terminator kit using ABI 310 Genetic Analyzer (Applied
Biosystems, USA). Almost complete sequence (1458 bp) of
16S rRNA of strain MTCC 8547 was determined and was
compared with those of other closely related taxa retrieved
from the GenBank database. A phylogenetic tree was
constructed by Neighbour-Joining plot (Perrière & Gouy
1996). A sequence similarity search was done using
GenBank BLASTN (Altschul et al. 1997). Sequences of
closely related taxa were retrieved; aligned using Clustal X
programme (Thompson et al. 1997) and the alignment was
manually corrected. For the Neighbour-joining analysis
(Saitou & Nei 1987), the distances between the sequences
were calculated using Kimura’s two-parameter model
(Kimura 1980). Bootstrap analysis was performed to assess
the confidence limits of the branching (Felsenstein 1985).
Growth and antibiotic production studies
Antibiotic production was studied in Potato dextrose
broth (PDB) and antibiotic production medium, GS
medium containing glucose 10 g, soyabean meal 10 g,
NaCl 10 g and CaCO3 1 g in 1 litre of water (Singh et al.
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GS to 7 before sterilization. Seed culture was prepared
in 100 ml Erlenmeyer flasks containing 25 ml GS
medium by inoculating a loopful from a slant culture
and incubating at 28°C in a shaker incubator at 150 rpm
for 48 hours. Antibiotic production was observed using
the same medium by inoculating 200 ml medium with
2.5% (v/v) of seed culture and cultivating under identical
incubation conditions for 8 days.
Effect of carbon and nitrogen
The effect of various carbon and nitrogen sources was
studied on growth as well as antibiotic production. Glu-
cose soyabean meal medium was used as a standard
medium. Carbon sources like starch, cellobiose, galact-
ose, mannose, raffinose, rhamnose, lactose, maltose,
fructose, sucrose, glycerol and xylose and nitrogen
sources like casein, peptone, yeast extract, tryptone and
jack bean meal were added at 1% concentration into the
standard media with appropriate controls. After 10 days,
each flask was harvested, the fermented broth as well as
the cells were extracted with ethyl acetate, the extracts
were dried in vacuum, resuspended in methanol to get a
clear solution and tested for antibiotic activity against
Bacillus subtilis. Growth was assessed by measuring cell
mass.
Isolation and purification of antimicrobial products
The mycelial cake obtained from 200 ml broth was
extracted with 100 ml acetone (Saito et al. 1995) and the
spent broth (200 ml) was extracted with 100 ml chloro-
form. The acetone extract was concentrated to one-
fourth original volume and then reextracted with 25 ml
chloroform. The resulting chloroform extracts were con-
centrated and then excess of 60-80°C petroleum ether
was added to obtain around 150 mg of crude antibiotic
complex (Eckardt et al. 1985).
The resulting dry broth and cell extracts were
resuspended in a small volume of methanol and were
tested for their antibacterial activity against B. subtilis by
agar well diffusion method, but there was hardly any ap-
preciable activity in the broth extract and hence it was
not pursued further. All the other studies were carried
out with only the cell extract. Preparative chromatog-
raphy with Silica gel plate 60 F 254 (Merck, Germany,
Cat # 1.05554.0007) was used for the partial purification
of antimicrobial products. The crude extract was spotted
and developed in the solvent system Chloroform: metha-
nol: 25% aqueous NH3 (85:14:1) (Johdo et al. 1991a;
Tobe et al. 1982). The developed plates were air dried
overnight to remove all traces of solvents. Seven well
separated bands were detected by observations of the
color of the bands, which were orange to red. The TLC
was repeated several times and the mean Rf of the bandswas calculated. The fractions were physically separated
from each other by scraping the bands from the plates,
extracting with methanol, concentrating the extracts and
again subjecting each concentrate to TLC using the
same solvent system, thereby obtaining each fraction in
substantially pure form.
Spectral studies
The UV-visible absorption spectra (190 nm-1100 nm) of
the TLC purified fractions were determined by using a
double beam bio-spectrophotometer, (BL-198, Elico
Ltd.). Futhermore, FT-IR spectrum of each active extract
was detected using Shimadzu IR-470 plus. The spectra
were scanned in the 400 to 4000 cm-1 range and plotted
as intensity versus wave number (Augustine et al. 2005).
Qualitative determination of aglycone and sugar residues
by TLC
To an aliquot of the purified fraction, 0.5 ml of 0.1 N
HCl was added and was heated at 85°C for 30 minutes
in a water bath. The pigment aglycone thus obtain-
ed was extracted with CHC13. The CHCl3 layer
was evaporated to dryness and the pigment residue
was chromatographed on a Silica gel plate 60 F 254
(Merck, Germany, Cat # 1.05554.0007) using CHCI3:
MeOH (15 : 1) mixture for chromatographic separ-
ation. The reference aglycones ε-rhodomycinone
(RMN) (red), ε-isorhodomycinone (isoRMN) (purple),
α-citromycinone (CTN) (yellow), α2-RMN (orange),
βRMN (red), β-isoRMN (purple) and γ-isoRMN (pur-
ple) are documented to have Rf values of 0.79, 0.77,
0.29, 0.27, 0.45, 0.43 and 0.59, respectively (Johdo et al.
1991a). The aglycones were also determined by spot
colors on the TLC plate.
Alternatively, the aqueous layer containing sugar
components was neutralized by adding silver carbonate
with a small amount of charcoal and centrifuged. The
supernatant fluid was concentrated in vacuo and chro-
matographed on TLC Silica gel 60 plate F254 (Merck,
Germany, Cat # 1.05554.0007) using a BuOH- acetic
acid - H2O (4 : 1 : 1) solvent system. The sugar spots
were detected with p-anisaldehyde - H2SO4 (each 5%)
in 90%EtOH spray reagent followed by heating at 90°
(Johdo et al. 1991a).
Bioactivity of the fractions
Each crude extract and purified fractions were tested
against Bacillus subtilis, Staphylococcus aureus, Escherichia
coli and Pseudomonas aeruginosa using agar well diffusion
technique. 15 μl of 1 mg/ml stock extracts were used for
the tests. The diameter of the inhibition zones was deter-
mined after 24 hours of incubation at 37°C. MIC of the
bioactive fractions was determined using broth dilution
technique (Wiegand et al. 2008).
Table 1 Physiological/Biochemical characteristics of
Streptomyces purpurascens
Characteristics S.purpurascens























+: Positve; -: negative.
The table details the biochemical properties associated with the isolate
providing the biochemical guidelines towards identity of the organism.
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The cytotoxicity of bioactive fractions on established cell
lines like HeLa and L929 was determined in vitro as de-
scribed by Mosmann (1983); Begde et al. (2010). The cell
lines were purchased from NCCS, Pune, India. Freshly
passaged HeLa cells were centrifuged and washed with
HBSS. The cell count was adjusted to 2.5 × 105 cells/ml
by suspending the cells in fresh DMEM with 10% FBS
(Invitrogen). This cell suspension was then transferred
to a 96-well TC plate for the assay and the cells were
allowed to grow for 24 hrs at 37°C. The spent medi-
um was discarded and the adherent cells were exposed
to a concentration gradient of each purified fraction
supplemented in the medium to a final concentration of
2.5, 5, 10, 15, 20, 25, 30 and 35 μM respectively. The
plate was incubated at 37°C in a humidified environment
with 5% CO2 in air for 48 h. After incubation the cells
were washed and resuspended in fresh medium con-
taining MTT (Himedia) and were further incubated for
3 hrs. The MTT formazan produced by the viable cells
was extracted in DMSO (BIOGENE Reagents Inc., CA,
USA) and quantified at 570 nm in the Bio-Rad ELISA
plate reader.
Results
During a screening program for natural bioactive prod-
ucts, several microorganisms were isolated and their
antimicrobial activity was studied. One of the cultures
showing antibacterial activity was found to be promising
and studied further.
Taxonomy of the producer organism
The morphological, physiological and cultural charac-
teristics indicated that the soil isolate belonged to the
genus Streptomyces. Streptomyces belong to the fami-
ly Streptomycetaceae of the order Actinomycetales
(Shirling & Gottlieb 1966). The physiological character-
istics and the cultural characteristics of the isolate are
summarized in the Tables 1 and 2 respectively.
The comparison of the partial sequences (1458 bp) of
16S rRNA of the isolate with those found in databases
was done by BLASTN analysis. Result showed that que-
ry sequence of the isolate was best pair-wise aligned
with 16S rRNA partial gene sequence of Streptomyces
purpurascens strain: KN-6 (AB231806.1, score value
2751 bits) with similar sequence homology and identity
of 100%. The N-J phylogenetic tree of the 16S rDNA se-
quence data confirmed that the isolate was most closely
related to S. purpurascens (Figure 1).
Out of 1458 16S rRNA nucleotides of the isolate all
were identical with those of S. purpurascens NBRC
13077, indicating that the sequence similarity of the 16S
rRNA of the two bacteria was 100%. The culture has
been deposited at Microbial Type Culture Collection,Institute of Microbial Technology, Chandigarh, India
(MTCC; http://mtcc.imtech.res.in/) as MTCC 8547.
Effect of carbon and nitrogen sources
Out of all the carbon sources tested for antibiotic pro-
duction, Starch was found to be the best followed by cel-
lobiose, raffinose, mannose and fructose. Of the nitrogen
sources tested for antibiotic production, Yeast extract
was the best followed by peptone and casein (Additional
file 2: Figure S1).
Physicochemical properties
The purified fractions were named as A, B, C, D, E, F
and G. The stock solutions were preserved at -20°C.
The UV visible light absorption spectra of the purified
fractions in methanol, against methanol blank exhibited
characteristic peaks of anthracyclines in the range of
297 nm, 492- 497, 522- 526 and 557 -562 (except D)
(Figure 2).
The FT-IR spectra (Figure 3) of all purified fractions in-
dicated the presence of hydroxyl group (3400-3300 cm-1)
Table 2 Cultural characteristics of S. purpurascens MTCC 8547
Media Color of mycelium Spores Reverse side Pigment
ISP1 Orange White + Orange Orange
ISP2 Orange White +++ Orange Orange diffusible
ISP3 Orange White + Orange Orange diffusible
ISP4 Orange White +++ Orange Orange diffusible
ISP5 Violet White +++ Violet Violet
ISP6 Yellow - Yellow Brown
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Table 2 Cultural characteristics of S. purpurascens MTCC 8547 (Continued)
ISP7 Pink - Pink No
PDA Orange White+++ Orange Orange
SDA Orange White+++ Orange Reddish orange
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hydrogen bonded carbonyl (1600 cm-1) which is character-
istic of anthracyclines (Oki 1979). The properties of all
fractions with their corresponding IR peaks are summa-
rized in Table 3.Qualitative determination of aglycone and sugars by TLC
On acid hydrolysis, followed by TLC analysis, the puri-
fied fractions separated into red, orange and purple agly-
cones and corresponding sugar components. Except D,
whose aglycone was found to be aklavinone, the agly-
cones of all the fractions were found to be rhodo-
mycinone (RMN). Fractions A and G gave α2-RMN, B
and E gave β-RMN, C gave ε-RMN and F gave γ
isoRMN on hydrolysis. These aglycones were peri-
hydroxy quinones was established by the color change of
the red- orange bands to violet on staining with 0.5%
ethanolic Magnesium acetate (Romanova et al. 1977).
The sugars of all the fractions were found to be
L-Rhodosamine and 2-deoxy-L- fucose by direct com-
parison with standard sugars on TLC. The details of the
aglycones and sugars are summarized in Table 4.Identification of compounds
Compound A appeared identical to α2-Rhodomycinone
glycoside, probably α2-Rhodomycin II, which has beenpreviously reported for S. purpurascens. Compound B
was found to contain β-RMN as the aglycone and
L-Rhodosamine as the sugar, which indicated that it may
be a Rhodomycin. The Rf and the UV–vis spectra of the
aglycone of B matched that of β- RMN. Also the UV–vis
spectra of B was found to be similar to that of S-583 A-II
(Shoji et al. 1968), which is reported to be a Rhodomycin
B. Therefore it was considered that B is similar to
Rhodomycin B. Compound C on acid hydrolysis yielded
ε-rhodomycinone (RMN) and L-Rhodosamine and deoxy
fucose as the sugars. Hence it was suspected to be a
ε-rhodomycinone glycoside. Johdo et. al., have named
such ε-rhodomycinone glycosides from S. violaceus as
Epelmycins (Johdo et al. 1991b). The UV spectrum of C
was found to match that of Epelmycin C with prominent
peaks at 237 nm, 495 nm and 522 nm. Also the Rf of puri-
fied C on silica gel TLC in solvent system CHCl3: MeOH
(8:1) was found to be 0.22 which coincided to the Rf of
Epelmycin C in the same solvent system as reported by
Johdo et. al. The FT-IR spectra (Figure 3) of C indicated
the presence of an ester carbonyl (1730 cm-1) and a hydro-
gen bonded carbonyl (1600 cm-1) group which are charac-
teristic of epelmycin anthracyclines (Johdo et al. 1991b).
Also the absence of non-chelated carbonyl absorption
(1670 cm-1) gave an indication that the aglycone could be
ε-RMN rather than aklavinone (Doyle et al. 1979). There-
fore this Rhodosaminosyl-decyfucosyl ε-rhodomycinone
Figure 1 Neighbour-joining tree based on 16S rRNA (1458 bases) sequences, showing the phylogenetic relationship between strain
MTCC 8547 and other phylogenetic neighbours. Streptosporangium roseum DSM 43021 T (X89947) was used as out group. Bootstrap values
expressed as percentage of 100 replications. Bar represents 1% sequence variation. Below is 1458 bp 16S rRNA gene sequence determined by the
dideoxy chain-termination method using the Big-Dye terminator kit. This sequence was used to perform the sequence similarity search using
GeneBank BLASTN based on which the phylogenetic tree was constructed by NJ plot.
Holkar et al. SpringerPlus 2013, 2:93 Page 7 of 13
http://www.springerplus.com/content/2/1/93could be an Epelmycin as reported by Johdo et. al., for
Streptomyces violaceus. Compound D was yellow in color
showing similarity to Aclacinomycin B. On hydrolysis, it
yielded aklavinone and the sugars, Rhodosamine and
deoxyfucose. D gave an Rf of 0.68 in CHCl3:MeOH:25%
aqNH3 which is reported for aclacinomycins in the same
solvent system. Its UV–vis spectra appeared similar to that
of aclcinomycin B with an absorption maxima at 437 nm.
Also the aglycone of D gave a single yellow band with anRf of 0.48 which coincided to the Rf of standard
alkavinone (Connors et al. 1990) under similar conditions.
It also exhibited a violet fluorescence which is reported for
aklavinone (Batel et al. 1990).
Compound E on acid hydrolysis yielded β-RMN and
the sugar L-Rhodosamine and even its FT-IR peaks
(Table 3 & Figure 3) appeared similar to rhodomycin.
Thus it resembled rhodomycin which is reported for
S. purpurascens. The band of compound F on TLC was
Figure 2 The UV visible absorption spectra of all the purified fractions, except D, exhibited characteristic peaks of anthracyclines in
the range of 297 nm, 492- 497 nm, 522- 526 nm and 557 -562 nm. Absorption spectra for all the fractions were recorded in methanol,
against methanol blank.
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aglycone γ-iso RMN giving an indication that it may be
similar to Obelmycin. The sugars detected in F were
L-Rhodosamine and deoxyfucose. The fact that F con-
tains γ-iso RMN and L-Rhodosamine and deoxyfucose
led us to believe that F could be Obelmycin F. The belief
was further strengthened by both having the same Rf
0.48 in CHCl3:MeOH:NH3 (80:10:1). Furthermore, the
UV-visible spectra of F and Obelmycin F showed coin-
ciding peaks at 297 nm, 492 nm and 527 nm. And even
the FT-IR spectra of F indicated the presence of hydro-
gen bonded carbonyl (1600 cm-1) which is characteristic
of Obelmycins. But Obelmycin F is reported to contain
L-Rhodinose along with L-Rhodosamine and 2-deoxy
fucose. However, F did not show the presence of
L-Rhodinose. F therefore was concluded to be similar to
L-Rhodosaminosyl deoxyfucosyl γ-iso rhodomycinone.
Compound G on acid hydrolysis yielded α2 rhodo-
mycinone, hinting that it may be a α2-RMN glycoside,
which have been designated as Alldimycins by Johdo et.
al in S. violaceus. The Rf of G in CHCl3:MeOH:NH3 was
0.17 which exactly matched that of Alldimycin B (Johdo
et al. 1991b). Also the UV–vis spectra showed a promin-
ent peak at 497 nm similar to Alldimycins. Alldimycins
have been reported to have only Rhodosamine as the
sugar (Johdo et al. 1991b) whereas the hydrolysis prod-
uct of G also yielded a spot for deoxy fucose on
the chromatogram. Therefore, G perhaps was a new
compound, resembling L- rhodosaminosyl, deoxyfucosyl
α2-rhodomycinone which needs further confirmation.Bioactivity of purified compounds
Antibacterial and antifungal activities were semi-
quantatively determined using agar well diffusion method
where, Compound E was found to have the highest activ-
ity against B. subtilis and S. aureus followed by compound
A. Compounds C and F demonstrated similar activities
whereas compounds D, G and B showed very weak activ-
ity (Figure 4). All the fractions failed to give any activity
against Gram negative bacteria and Candida albicans.
The MIC of compounds E, A and F was determined
against B. subtilis by broth dilution method. The com-
pound E was found to be very active with an MIC of
2 μg/ml whereas compounds A and F were compara-
tively less active with an MIC greater than 20 μg/ml.
Furthermore, the compounds E, A and F were found
to be active against human cervical carcinoma HeLa
cells with an IC50 of for E ~15 μM. However, in the
tested range, these compounds did not demonstrate any
appreciable cytotoxicity against mouse subcutaneous fi-
broblasts, L929 cells.
Discussion
In our screening program for anthracycline producers
from soil, a Streptomyces sp. was isolated from soil. The
isolate was identified as Streptomyces purpurascens by 16S
rRNA gene sequencing and deposited in Microbial Type
Culture Collection (MTCC), Chandigarh, India (http://
mtcc.imtech.res.in/) with the accession number MTCC
8547. The isolate was found to produce rhodo-
mycins which are reported for S. purpurascens. Apart
Figure 3 FT-IR spectrum of some major purified compounds. The purified and dried compounds were ground in KBr and absorbances were
recorded in the range 400-4000 cm-1 to generate the FT-IR spectra. The FT-IR Spectra of four major compounds A, C, E and F are shown here. All
purified fractions consistently indicated the presence of hydroxyl group (3400-3300 cm-1) a ketonic group or ester carbonyl (1740 cm-1) and a
hydrogen bonded carbonyl (1600 cm-1) which are characteristics of anthracyclines. For more detailed FT-IR peak positions refer Table 3.
Holkar et al. SpringerPlus 2013, 2:93 Page 9 of 13
http://www.springerplus.com/content/2/1/93from this, some rhodomycin analogues which were not
reported for S. purpurascens before were also obtained. In
the present study at least one new rhodomycin analogue,
was obtained from this isolate.
The isolate when grown in liquid culture produced
red colored pigments extracellularly. Preliminary testing
using the crude cell extract of the isolate showed it to be
antibacterial against Gram positive bacteria. However,
the crude extracts were not found to be active against
Gram negative bacteria nor were they antifungal.
Studies on optimization of the growth medium indi-
cated Starch as the best carbon source for growth as well
as antibiotic production whereas yeast extract and pep-
tone served as the best nitrogen source for antibiotic
production and for growth respectively (For more details
refer to Additional files). Therefore for all the further
antibiotic production procedures the Starch-Yeastextract medium was preferred. Solvent extraction of the
spent broth and subsequent purification using prepara-
tive TLC helped in obtaining the purified compounds.
Seven purified compounds thus obtained were named
A, B, C, D, E, F and G.
The UV visible spectra of all the fractions showed a
peak in the 230-290 nm region indicating the presence
of an aromatic ring in the structure. Also the FT-IR
spectra of the compounds indicated the presence of
hydroxyl groups, ketonic groups and hydrogen- bonded
carbonyl groups which are characteristic of anthra-
cyclines. Hence it was speculated that the isolate was
an anthracycline producer. Identification of our isolate
as S. purpurascens further strengthened the supposi-
tion since it is well known to produce anthracyclines be-
longing to the rhodomycin group (Brockmann & Bauer
1950). On acid hydrolysis each compound yielded an
Table 3 Tabulation of the physical and chemical properties of the compounds purified by preparative Thin Layer
Chromatography
Properties A B C D E F G







ND ND C42H51NO16 C42H53NO15 C36H48N2O12 C40H53NO15 C36H48N2O12
Melting point (˚C) ND 184-190 175-178 151-153 185-190 160-163 134-137
UV λmax (nm) 237(2.014), 297(0.508), 237(1.963), 287(1.751), 297(1.023), 297(1.072), 297(0.552),
257(2.11), 463(sh), 257(sh), 317 (1.74), 497(1.923), 492(0.834), 377(0.101),
284(1.957), 492(0.472), 495(0.483), 375 (1.59), 517(sh), 527(sh) 497(0.304)
492(0.614), 526(sh), 522(0.415), 412 (1.401) 561(0.792)
522(0.635), 562(sh) 562(sh) 437 (1.172)
557(0.461)
IRmax(KBr) (cm
-1) 3780, 3763, 3760, 3432, ND 3394, 2922, 3780, 2924, ND
2924, 2922, 2924, 1736, 1736,











Rf valuea 0.88 0.80 0.79 0.68 0.62 0.48 0.17
a the values were obtained on silica gel TLC, CHCl3: MeOH: 25% aqNH3 (85:14:1); ND- Not Determined.
The table provides details about the UV–vis and FT-IR absorption peaks of respective purified compounds necessary for their identification.
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and sugars (by TLC) confirmed that these compounds
might be rhodomycin and/or its anaologues (Johdo et al.
1991a).
Compound A appeared very similar to α2-Rhodomycin
II and compounds B and E to that of Rhodomycins,
which perhaps could be Rhodomycin A or B depending
upon whether there are two rhodosamine moieties or




A 0.27 α2 –RMN 0.56
B 0.45 β RMN 0.56
C 0.79 ε RMN 0.56
D 0.67 Aklavinone 0.12
0.56
E 0.45 β-RMN 0.12
0.56
F 0.59 γ-iso RMN 0.12
0.56
G 0.27 α2 –RMN 0.12
0.56
a: CHCl3 : MeOH (15:1), b: Butanol: acetic acid: water (4:1:1).
Identification of the sugars and aglycones were done by comparing their Rf with thfor S. purpurascens by Brockman (1955) and Shoji
(1968; Arcamone 1984).
From our study, compound C appeared to be similar
to an ε-RMN glycoside, Epelmycin and compound F re-
sembled to an γ-isoRMN glycoside, Obelmycin. To the
best of our knowledge, these compounds have not yet
been reported for S. purpurascens. They have, however
been reported for mutants of S. violaceus (Johdo et al.
1991c), which is very closely related and a phylogeneticent groups of all the isolated anthracyclines obtained
Compound
predictedColor Sugar detected
grayish blue 2-deoxy-L- fucose α2-Rhodomycin II
grayish blue L-Rhodosamine Rhodomycin
2-deoxy-L- fucose
grayish blue 2-deoxy-L- fucose Epelmycin B
sky blue L-Rhodosamine Aclacinomycin A
grayish blue 2-deoxy-L- fucose
sky blue L-Rhodosamine Rhodomycin A or B
grayish blue 2-deoxy-L- fucose
sky blue L-Rhodosamine Obelmycin
grayish blue 2-deoxy-L- fucose
sky blue L-Rhodosamine Alldimycin B
grayish blue 2-deoxy-L- fucose
at of the standards under similar TLC solvent conditions.
Figure 4 (i) Preparative TLC- For the partial purification of antimicrobial products preparative thin layer chromatography was performed.
The crude extract got resolved into seven well separated colored bands when developed in the Chloroform: Methanol: 25% aqueous NH3 (85:14:1)
solvent system. According to the Rf value, each fraction was named from A to D. (ii) Antimicrobial activity of the isolated fractions against B. subtilis
and S. aureus determined by agar well diffusion assay. Zone of inhibition associated with each fraction against respective test organisms is depicted.
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The biosynthetic pathway for rhodomycin synthesis has
been elucidated by Oki (1977), according to which during
the synthesis of rhodomycin (a β-RMN glycoside), ε-RMN
is an intermediate. This ε-RMN can be glycosylated by a
glycosyl transferase to form ε-RMN glycosides, epelmy-
cins. It has been suggested that biosynthetic conversion
from ε-RMN to β-RMN takes place at glycoside level
(Johdo et al. 1991b; Johdo et al. 1991c). Therefore forma-
tion of Epelmycins which are ε-RMN glycosides can
be expected to occur in S. pupurascens too. Similarly,
Compound D identified as an aklavinone glycoside,Aclacinomycin A which is the main product in S. galilaeus
has also not been reported for S. purpurascens. Aklavinone
is the first aglycone during the synthesis of rhodomycin
(Connors et al. 1990). Aklavinone can be glycosylated by a
glycosyl transferase to form Aclacinomycin (Oki et al.
1979). Hence the possibility of obtaining aclacinomycins
in the fermentation broth of S. purpurascens cannot be
denied.
Compound G was identified as Rhodosaminyl-2-
Deoxyfucosyl-α2 Rhodomycinone. α2-RMN glycosides
have been designated as Alldimycins by Johdo (Johdo
et al. 1991d). All Alldimycins have been reported to
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http://www.springerplus.com/content/2/1/93contain only one sugar, Rhodosamine. Our studies con-
sistently showed the presence of 2-deoxy fucose in the
chromatogram of compound G. This leads us to be-
lieve that compound G may be a new rhodomycin
analogue which has not been previously reported.
Antibacterial studies showed that compound E which
appeared similar to Rhodomycin B was the most potent
compound. Its MIC was found to be 2 μg/ml which was
comparable to the reported value of 0.5-1 μg/ml (Shoji
et al. 1968). However, the IC50 value, around 15 μM
(~8 μg/ml) indicating much less toxicity than the
reported value of 1 μg/ml (Saito et al. 1995).
Compound A, identified as α2-Rhodomycin II and
compound F, identified as Obelmycin were found to be
less potent. The MIC of both A and F was found to
be > 20 μg/ml and IC50 was found to be around 15 μM
(~8 μg/ml), which is much higher than the reported
values. Compound F appeared similar to Obelmycins
which are γ-isoRMN glycosides. These are reported to
have low bioactivity because the sugar rhodosamine is
bound at C-10 of the carbon skeleton (Johdo et al.
1991e). According to Vanek et al.(1977), the position of
sugar moiety on the carbon skeleton is important.
Anthracycline glycosides having C-7 sugar are more ac-
tive than those having it at C-10.
Thus this study resulted in the isolation of a rhodomycin
producer from soil and its identification as Streptomyces
purpurascens. The isolate was found to produce one novel
Rhodomycin analogue and two known analogues being
reported however, first time from S. purpurascens.
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